Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: Protocadherin17 (PCDH17) is a tumor suppressor gene, and is frequently silenced by promoter methylation in human cancers, including clear cell renal cell carcinoma (ccRCC). However, the clinical significance of PCDH17 methylation in ccRCC remains largely unclear. The aim of the present study was to investigate the methylation status of PCDH17 in ccRCC and its potential relevance to clinicopathological parameters and prognosis.
Material And Methods: Methylation-specific PCR was used to examine the methylation status of PCDH17 in 191 ccRCC tumors and matched paired adjacent noncancerous tissues. Subsequently, the associations between PCDH17 methylation and clinicopathological parameters and prognosis of patients with ccRCC were analyzed.
Results: PCDH17 methylation occurred in 66.5% of ccRCC tumors, but in only 12.1% of adjacent noncancerous tissues. PCDH17 methylation is significantly correlated with advanced stage, higher grade, and lymph node metastasis in ccRCC. Moreover, it is an independent prognostic factor for progression-free survival and overall survival of patients with ccRCC.
Conclusions: PCDH17 methylation occurred more frequently and was associated with malignant clinicopathological characteristics and poor prognosis in ccRCC patients. Thus, PCDH17 methylation may be used as a novel biomarker to predict the prognosis of patients with ccRCC.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4588677 | PMC |
| http://dx.doi.org/10.12659/MSM.895603 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Correlation analysis of circulating PCDH17 DNA methylation changes with rheumatoid arthritis patients.
Sci Rep
May 2025
Department of Rheumatology, Guanghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Guanghua, China.
Analyze the correlation between the DNA methylation levels of Protocadherin 17 (PCDH17) cg03865667 and rheumatoid arthritis (RA), and evaluate its potential as a biomarker for diagnosing RA. Peripheral blood samples were collected from a cohort of 370 individuals, comprising patients diagnosed with RA, ankylosing spondylitis (AS), psoriatic arthritis (PsA), gout, systemic lupus erythematosus (SLE), dermatomyositis (DM), primary Sjögren's syndrome (SS), and healthy controls (HC), for subsequent analysis.DNA methylation sequencing techniques were employed to evaluate the methylation levels of the PCDH17 cg03865667 locus.
View Article and Find Full Text PDFEpigenetic modulation of the NLRP6 inflammasome sensor as a therapeutic modality to reduce necroptosis-driven gastrointestinal mucosal dysfunction in HIV/SIV infection.
Cell Commun Signal
April 2025
Southwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX, USA.
Background: Gastrointestinal (GI) disease/dysfunction persists in people living with HIV (PLWH) receiving suppressive combination anti-retroviral therapy (ART) leading to epithelial barrier breakdown, microbial translocation and systemic inflammation that can drive non-AIDS associated comorbidities. Although epigenetic mechanisms are predicted to drive GI dysfunction, they remain unknown and unaddressed in HIV/SIV infection. The present study investigated genome-wide changes in DNA methylation, and gene expression exclusively in colon epithelial cells (CE) in response to simian immunodeficiency virus infection (SIV) and long-term low-dose delta-9-tetrahydrocannabinol (THC).
View Article and Find Full Text PDFPCDH17 gene promoter methylation status in a cohort of Egyptian women with epithelial ovarian cancer.
BMC Cancer
January 2023
Department of Clinical and Chemical Pathology, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Background And Objective: Ovarian cancer is a leading cause of female mortality. Epigenetic changes occur in early stages of carcinogenesis and represent a marker for cancer diagnosis. Protocadherin 17 (PCDH17) is a tumor suppressor gene involved in cell adhesion and apoptosis.
View Article and Find Full Text PDFPlasma cell-free DNA methylome profiling in pre- and post-surgery oral cavity squamous cell carcinoma.
Mol Carcinog
April 2023
Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA.
Head and neck squamous cell carcinoma (HNSCC), a highly heterogeneous disease that involves multiple anatomic sites, is a leading cause of cancer-related mortality worldwide. Although the utility of noninvasive biomarkers based on circulating cell-free DNA (cfDNA) methylation profiling has been widely recognized, limited studies have been reported so far regarding the dynamics of cfDNA methylome in oral cavity squamous cell carcinoma (OCSCC). It is hypothesized in this study that comparison of methylation profiles in pre- and postsurgery plasma samples will reveal OCSCC-specific prognostic and diagnostic biomarkers.
View Article and Find Full Text PDFMethylation of PCDH17 and NEFH as prognostic biomarker for nonmetastatic RCC: A cohort study.
Medicine (Baltimore)
July 2022
First Department of Urology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.
DNA methylation makes up a main part of the molecular mechanism of cancer evolution and has shown promising results in the prognosis of renal cell cancer (RCC). In this study, we investigated the possible association of promoter methylation of PCDH17, NEFH, RASSF1A, and FHIT, genes with the prognosis of nonmetastatic RCC patients. Cancerous and normal adjacent tissues from surgical specimens of 41 patients with long follow-up were treated for DNA isolation and bisulfite conversion.
View Article and Find Full Text PDF